Insomnia and Paranasal sinus hypersecretion

Summary:

Paranasal sinus hypersecretion is found among people with Insomnia, especially for people who are female, 60+ old.

The study analyzes which people have Paranasal sinus hypersecretion with Insomnia. It is created by eHealthMe based on reports of 32 people who have Insomnia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 05, 2023

32 people who have Insomnia and Paranasal Sinus Hypersecretion are studied.

What is Insomnia?

Insomnia (sleeplessness) is found to be associated with 4,595 drugs and 4,883 conditions by eHealthMe.

What is Paranasal sinus hypersecretion?

Paranasal sinus hypersecretion is found to be associated with 747 drugs and 395 conditions by eHealthMe.

Number of Paranasal sinus hypersecretion in Insomnia reports submitted per year:

Would you have Paranasal sinus hypersecretion when you have Insomnia?

Gender of people who have Insomnia and experienced Paranasal Sinus Hypersecretion *:

female: 81.25 %
male: 18.75 %

Age of people who have Insomnia and experienced Paranasal Sinus Hypersecretion *:

Common co-existing conditions for these people *:

High Blood Pressure: 11 people, 34.38%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 11 people, 34.38%
Pain: 9 people, 28.12%
Stress And Anxiety: 9 people, 28.12%
Depression: 9 people, 28.12%
High Blood Cholesterol: 9 people, 28.12%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 25.00%
Diabetes: 7 people, 21.88%
Neuropathy Peripheral (surface nerve damage): 7 people, 21.88%
Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 7 people, 21.88%

Common drugs taken by these people *:

Common symptoms for these people *:

Cough: 15 people, 46.88%
Nasopharyngitis (inflammation of the nasopharynx): 7 people, 21.88%
Sinus Disorder (disease of sinus): 7 people, 21.88%
Irritable Bowel Syndrome: 6 people, 18.75%
Joint Pain: 6 people, 18.75%
Pain: 6 people, 18.75%
Drug Ineffective: 5 people, 15.62%
Injection Site Pain: 5 people, 15.62%
Fever: 4 people, 12.50%
Fatigue (feeling of tiredness): 4 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Paranasal sinus hypersecretion?

Check whether Paranasal sinus hypersecretion is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

Insomnia (387,957 reports)
Paranasal sinus hypersecretion (4,043 reports)

COVID vaccines that are related to Paranasal sinus hypersecretion:

Common drugs associated with Paranasal sinus hypersecretion:

How the study uses the data?

The study is based on Paranasal sinus hypersecretion and Insomnia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.